Potential influence of tacrolimus and steroid avoidance on early graft function in pediatric renal transplantation

Pediatric Transplantation

Volumn 12, Issue 6, 2008, Pages 701-707

  Li, L ^a   Weintraub, L ^a   Concepcion, W ^a   Martin, J P ^a   Miller, K ^b   Salvatierra, O ^a   Sarwal, M M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

Graft function; Pediatric renal transplant; Steroid avoidance; Tacrolimus

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CREATININE CLEARANCE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RECIPIENT; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CHILD; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PEDIATRICS; RETROSPECTIVE STUDIES; STEROIDS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 49449086364     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00884.x     Document Type: Article

References (24)

1. Johnston O, O'Kelly P, Spencer S, et al. Reduced graft function (with or without dialysis) vs immediate graft function - A comparison of long-term renal allograft survival. Nephrol Dial Transplant 2006: 21: 2270 2274.
2. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: Etiology, management and long-term significance. J Urol 1996: 155: 1831 1840.
3. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997: 63: 968 974.
4. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006: 21: 1689 1696.
5. Boger CA, Rummele P, Mihatsch MJ, Banas B, Kramer BK. Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity. Am J Transplant 2006: 6: 1963 1967.
6. Kandaswamy R, Melancon JK, Dunn T, et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients - An interim analysis. Am J Transplant 2005: 5: 1529 1536.
7. Khwaja K, Asolati M, Harmon J, et al. Outcome at 3 years with a prednisone-free maintenance regimen: A single-center experience with 349 kidney transplant recipients. Am J Transplant 2004: 4: 980 987.
8. Cole E, Landsberg D, Russell D, et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001: 72: 845 850.
9. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13 21.
10. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O, Jr. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003: 76: 1331 1339.
11. Silverstein DM, Aviles DH, LeBlanc PM, Jung FF, Vehaskari VM. Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients. Pediatr Transplant 2005: 9: 589 597.
12. Roberti I, Reisman L, Lieberman KV, Burrows L. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up). Clin Transplant 1994: 8: 405 408.
13. Pascual J, Quereda C, Zamora J, Hernandez D. Updated meta-analysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil. Transplant Proc 2005: 37: 3746 3748.
14. Oberholzer J, John E, Lumpaopong A, et al. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Pediatr Transplant 2005: 9: 456 463.
15. Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985: 106: 522 526.
16. Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984: 104: 849 854.
17. Kim JS, Aviles DH, Silverstein DM, Leblanc PL, Matti Vehaskari V. Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients. Pediatr Transplant 2005: 9: 162 169.
18. Anglicheau D, Flamant M, Schlageter MH, et al. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol Dial Transplant 2003: 18: 2409 2414.
19. Cecka JM. The OPTN/UNOS renal transplant registry. In: Cecka JM, Terasaki PL, eds. Clinical Transplant 2004. Los Angeles, UCLA Tissue Typing Laboratory, 2005: 1 16.
20. Gok MA, Shenton BK, Pelsers M, et al. Reperfusion injury in renal transplantation: Comparison of LD, HBD and NHBD renal transplants. Ann Transplant 2004: 9: 33 34.
21. Martins L, Ventura A, Branco A, et al. Cyclosporine versus tacrolimus in kidney transplantation: Are there differences in nephrotoxicity? Transplant Proc 2004: 36: 877 879.
22. Lucey MR, Abdelmalek MF, Gagliardi R, et al. A comparison of tacrolimus and cyclosporine in liver transplantation: Effects on renal function and cardiovascular risk status. Am J Transplant 2005: 5: 1111 1119.
23. El-Asir L, Wilson CH, Talbot D. Interleukin 2 receptor blockers may directly inhibit lymphocyte mediated ischaemia reperfusion injury. Transpl Int 2005: 18: 1116.
24. Sarwal MM, Cecka JM, Millan MT, Salvatierra O, Jr. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: A single center and UNOS analysis. United Network for Organ Sharing. Transplantation 2000: 70: 1728 1736.